The goal of the partnership is to develop synthetic datasets to train vision language action models on various experimental workflows ...

Preclinical results indicate new approach could be a way to deliver treatment directly to tumors at higher doses, while reducing side effects in healthy tissue.

Active Genetics (Pro-AG) exploits a naturally created bacterial mating tunnel between cells to inactivate antibiotic resistance.

Researchers elucidated the connection between influenza infection and cardiac disease in mammals by studying human and mouse hearts.

In a study using gut microbiome samples from over 11,000 people across 39 countries, a single group of bacteria (CAG-170) has been found in higher numbers in the gut microbiomes of healthy people. CAG ...

Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule drugs through a multi-year tech and ...

Bristol Myers Squibb (NYSE: BMY; BMS) beat analyst consensus forecasts by reporting higher than expected numbers for total revenue and its “growth” portfolio of drugs on which BMS is counting on for ...

A gene expression program executed by neutrophils and a corresponding biomarker support tumor progression across human and murine tumors.

HIEs were used to identify why the growth of norovirus in culture stops and to determine methods to maintain growth.

Shweta Maniar, global director, life sciences strategy & solutions for Google Cloud, recently discussed with GEN Edge the survey and the broader challenges faced by life sciences and healthcare users ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Immunotherapy that blocks microglial Fcγ receptors prevents dopaminergic neuron loss in Parkinson’s disease, revealing a potential new strategy.